Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-04-10
1997-08-05
Feisee, Lila
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530350, 4241341, 4241361, 4241781, C07K 14435, C12P 2108, A61K 3900, A61K 3816
Patent
active
056544049
ABSTRACT:
The present invention provides methods for preventing occurrence or progression of liver damage using hepatocyte growth factor. In the methods, a preventatively effective amount of the hepatocyte growth factor is administered to the patient. The hepatocyte growth factor can be administered, for instance, prior to administering a hepatotoxic therapy to the patient. The hepatocyte growth factor can further be administered with activin or transforming growth factor-beta to prevent liver damage. Compositions comprising hepatocyte growth factor and activin antagonist or transforming growth factor-beta antagonist are also provided by the invention.
REFERENCES:
patent: 5004805 (1991-04-01), Gohda et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5196192 (1993-03-01), DeKretzer et al.
patent: 5227158 (1993-07-01), Jardeau
patent: 5316921 (1994-05-01), Godowski
An, W., et al., "Protective Effect of Hepatic Stimulator Substance Against Experimental Acute Liver Failure in Mice", Acta Physiol Sin., 43(5):415-427 (1991).
An, W. et al., "A Study of the Protective Mechanism of Hepatic Stimulator Substance Against Experimental Acute Liver Failure In Mice" Acta Physiol. Sin., 44(1):54-61 (1992)(Abstract Only).
Andus, et al., "Effects of Cytokines on the Liver", Hepatology, 13(2):364-375 (1991).
Armendariz-Borunda, et al., "Regulation of TGF.beta. Gene Expression in Rat Liver Intoxicated with Carbon Tetrachloride", FASEB J., 4:215-221 (1990).
Asami, et al., "Purification and Characterization of Hepatocyte Growth Factor from Injured Liver of Carbon Tetrachloride-Treated Rats", J. Biochem., 109:8-13 (1991).
Awwad, et al., "Late Tissue Reactions After Single-Fraction Sequential Half-Body Irradiation (HBI) In Patients with Non-Hodgkin's Lymphomas", Int. J. Radiat. Oncol. Biol. Phys., 19(5):1229-1232 (1990).
Baglin, et al., "Veno-Occlusive Disease of the Liver Complication ABMT Successfully Treated with Recombinant Tissue Plasminogen Activator (rt-PA)", Bone Marrow Transplant, 5(6):439-441 (1990).
Benhamou, J-Pierre, "Drug-Induced Hepatitis: Clinical Aspects", Livers Cells and Drugs, Chapter 164, pp.3-12, Colloque INSERM/John Libbey Eurotext Ltd., edited by A. Guillozo (1988).
Berse, et al., "Vascular Permeability Factor (Vascular Endothelial Growth Factor) Gene is Expressed Differentially in Normal Tissues, Macrophages, and Tumors", Mol. Biol. Cell, 3(2):211-220 (Feb. 1992).
Borisuth, et al., "Identification and Partial Characterization of TGF-.beta.1 Receptors on Trabecular Cells", Invest. Opthal. and Vis. Sci., 33:596-603 (Mar. 1992).
Bottaro, et al., "Identification of the Hepatocyte Growth Factor Receptor as the C-Met Proto-Oncogene Product", Science, 251:802-804 (1991).
Braun, et al., "Transforming Growth Factor .beta. mRNA Increases During Liver Regeneration: A Possible Paracrine Mechanism of Growth Regulation", Proc. Natl. Acad, Sci., 85:1539-1543 (Mar. 1988).
Carr, et al., "Inhibition of DNA Synthesis in Rat Hepatocytes by Platelet-Derived Type .beta. Transforming Growth Factor", Cancer Research, 46:2330-2334 (1986).
Castilia, et al., "Transforming Growth Factors .beta., and .alpha. in Chronic Liver Disease", New Engl. J. Med., 324:933-940 (Apr., 1991).
Chan, et al., "Identification of a Competitive HFG Antagonist Encoded by an Alternative Transcript", Science, 254:1382-1385 (1991).
Chelfetz, et al., "Isoform-Specific TGF.beta. Binding Proteins Sensitive to PIPLC", J. Cell Biochem., 16(Part B):121 (Jan., 1992) (Abstract Only).
Cohen, et al., Am. J. Surg., 145:529-533 (1983).
Cooper, "The Met Oncogene: From Detection by Transfection to Transmembrane Receptor for Hepatocyte Growth Factor", Oncogene, 7:3-7 (1992).
Cooper, et al., "Amplification and Overexpression of the Met Genen in Spontaneously Transformed NIH3T3 Mouse Fibroblasts", EMBO J., 5:2623 (1986).
Cornelius, "Liver Function Tests in the Differential Diagnosis of Hepatotoxicity", Hepatotoxicology, Chapter 5, pp.181-185 (1991).
DePaolo, et al, "Follistatin and Activin: A Potential Intrinsic Regulatory System within Diverse Tissues" (43286A), Dept. of Molec. Endocrinol., La Jolla, CA:The Whittier Inst. for Diabetes and Endocrinol., pp.500-512 (1991).
Dong, et al., "Research on the Treatment of Severe Hepatitis and on the Mechanism of its Therapeutic Effectiveness", Chinese J. of Internal Med., 30(10):637-639 (1991).
Dong, et al., "Study on Hepatocyte Growth Factor in the Treatment of Chronic Active Hepatitis", J. China Med. Univ., 21(2):132-134 (1992) (Abstract Only).
Dong, et al., "Hepatocyte Growth Factor in the Treatment of Fulminant Viral Hepatitis and Its Therapeutic Mechanism", J. China Med. Univ., 21(2):135-138 (1992).
Fajardo, et al., "Pathogenesis of Veno-occlusive Liver Disease After Radiation", Arch. Pathol. Lab. Med., 104(11):584-8 (Nov. 1980).
Giordano, et al., "Tyrosine Kinase Receptor Indistinguishable from the C-Met Protein", Nature, 339:155 (May 1989).
Gohda, et al., "Purification and Partial Characterization of Hepatocyte Growth Factor from Plasma of a Patient with Fulminant Hepatic Failure", J. Clin. Invest., 81:414-419 (Feb. 1988).
Gilman, et al., "Analgesic-Antipyretics and Antiinflammatory Agents", Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th Edition, Gilman, et al., pp. 658-659 (1985).
Han, et al., "Characterization of the DNF15S2 Locus on Human Chromosome 3: Identification of a Gene Coding for Four Kringle Domains with Homology to Hepatocyte Growth Factor", Biochem., 30:9768-9780 (1991).
Houck, et al., "Norepinephrine Modulates the Growth-Inhibitory Effect of Transforming Growth Factor-Beta in Primary Rat Hepatocyte Cultures", J. Cell. Phys., 135:551-555 (1988).
Huang, et al., "Changes of Tumor Necrosis Factor Activity and Protective Effect of Hepatocyte Growth Factor and Prostaglandin E1 in Liver", Zhonogguo Yike Daxue Xuebao, 22:275-8 (1993) (Abstract Only).
Igawa, et al., "Hepatocyte Growth Factor is a Potent Mitogen for Cultured Rabbit Renal-Tubular Epithelial Cells", Biochem. Biophys. Res. Commun., 174:831-838 (1991).
Lin, et al., "Expression Cloning of TGF-.beta. Type II Receptor, a Functional Transmembrane Serine/Threonine Kinase, Cell, 68:775-785 (Feb., 1992).
Lin, et al., "Expression Cloning of the Type II TGF-.beta. Receptor", J. Cell. Biochem., 16 Part B:125 (Feb., 1992) (Abstract Only).
Lindroos, et al., "Hepatocyte Growth Factor (Hepatopoletin A) Rapidly Increases in Plasma before DNA Synthesis and Liver Regeneration Stimulated by Partial Hepatectomy and Carbon Tetrachloride Administration", Hepatol., 13:734-750 (1991).
Ling, et al., "Pituitary FSH is released by a Heterodimer of the .beta.-Subunits from the Two Forms of Inhibin", Nature, 321:779-782 (Jun., 1986).
Mason, et al., "Activin B: Precursor Sequences Genomic Structure and in Vitro Activities", Molecular Endocrinology, 3(9):1352-1358 (1989).
Mason, et al., "Human Inhibin and Activin: Structure and Recombinant Expression in Mammalian Cells", Inhibin-Non-Steroidal Regulation of Follicle Stimulating Hormone Secretion, Raven Press:Serono Symposia Publications, Vol. 42:77-88 (1987).
Mason, et al., "Structure of Two Human Ovarian Inhibin", Biochem. and Biophys. Res. Comm., 135(3):957-964 (Mar., 1986).
Matsumoto, et al., "Hepatocyte Growth Factor is a Potent Simulator of Human Melanocyte DNA Synthesis and Growth", Biochem. Biophys. Rec. Commun., 176:45-51 (1991).
Mbidde, et al., Br. J. Cancer, 58:779-782 (1988).
McCracken, et al., "Adjuvant Intrahepatic Chemotherapy with Mitomycin and 5-FU Combined with Hepatic Irradiation in High-Risk Patients with Carcinoma of the Colon: A Southwest Oncology Group Phase II Pilot Study", Cancer Treat Rep., 69(1):129-31 (1985).
McIntyre, et al., "Fata Veno-Occlusive Disease of the Liver Following High-Dose 1,3-Bis (2-Chloroethyl)-1-nitrosourea (BCNU) and Autologous Bone Marrow Transplantation", American Society of Clinical Pathologies, 75(4):614-617 (1981).
Michalopoulos, FASEB J., 4:176-1897 (1990).
Miyazawa, et al., "An Alternatively Processed mRNA Generated from Human Hepatocyte Growth Factor Gene", Eur. J. Biochem., 197:15-22 (1991).
Miyazawa, et al., "Molecular Cloning and Seq
Roos Filip
Schwall Ralph
Feisee Lila
Genentech Inc.
Lucas John
LandOfFree
Protection against liver damage by HGF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protection against liver damage by HGF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protection against liver damage by HGF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1075795